These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 2666224)
1. [Evaluation of beta cell function in non-insulin-dependent diabetes mellitus (NIDDM) and its correlations with clinico-metabolic parameters]. Santoro E; Gianni R; Maggi L; Tomassini CR; Bisacchi U G Clin Med; 1989 Feb; 70(2):95-9. PubMed ID: 2666224 [TBL] [Abstract][Full Text] [Related]
2. [Clinical usefulness of the glucagon test in the study of pancreatic islet cell function]. Llorente I; Goñi MJ; Forga L; Monreal M; Lizcano F; Moncada E Rev Med Univ Navarra; 1992; 37(1):25-9. PubMed ID: 1626165 [TBL] [Abstract][Full Text] [Related]
3. The role of diminished beta cell reserve and insulin resistance in secondary sulfonylurea failure of type 2 diabetes mellitus. Rattarasarn C; Thamprasit A; Leelawattana R; Soonthornpun S; Setasuban W J Med Assoc Thai; 2001 Dec; 84(12):1754-62. PubMed ID: 11999824 [TBL] [Abstract][Full Text] [Related]
4. C-peptide response to glucagon in type 2 diabetes mellitus: a comparison with oral glucose tolerance test. Iwasaki Y; Kondo K; Hasegawa H; Oiso Y Diabetes Res; 1994; 25(3):129-37. PubMed ID: 7671552 [TBL] [Abstract][Full Text] [Related]
5. Estimation of B-cell function by the urinary excretion rate of C-peptide in diabetic patients: comparison with C-peptide response to glucagon and to a mixed meal. Pasquali R; Buratti P; Biso P; Patrono D; Capelli M; Pasqui F; Melchionda N Diabete Metab; 1987 Feb; 13(1):44-51. PubMed ID: 3552774 [TBL] [Abstract][Full Text] [Related]
6. Pancreatic beta cell response in insulin treated NIDDM patients limitations of a random C-peptide measurement. Snehalatha C; Ramachandran A; Mohan V; Viswanathan M Diabete Metab; 1987 Feb; 13(1):27-30. PubMed ID: 3552773 [TBL] [Abstract][Full Text] [Related]
7. C-peptide response to glucagon in diabetics with and without complications. Smith RB; Pyke DA; Watkins PJ; Binder C; Faber OK N Z Med J; 1979 Apr; 89(634):304-6. PubMed ID: 377156 [TBL] [Abstract][Full Text] [Related]
8. Residual B-cell function in insulin dependent (Type 1) and non insulin-dependent (Type 2) diabetics (relationship between 24-hour C-peptide excretion and the clinical features of diabetes). Gerö L; Korányi L; Tamás G Diabete Metab; 1983 Sep; 9(3):183-7. PubMed ID: 6360742 [TBL] [Abstract][Full Text] [Related]
10. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients. van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393 [TBL] [Abstract][Full Text] [Related]
11. The beta-cell response to glucagon and mixed meal stimulation in non-insulin dependent diabetes. Gjessing HJ; Damsgaard EM; Matzen LE; Faber OK; Frøland A Scand J Clin Lab Invest; 1988 Dec; 48(8):771-7. PubMed ID: 3070718 [TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of measuring serum c-peptide before and after glucagon injection]. Kan Y; Chi Z Zhonghua Yi Xue Za Zhi; 1991 Jan; 71(1):16-7, 4. PubMed ID: 1850647 [TBL] [Abstract][Full Text] [Related]
13. Reproducibility of beta-cell function estimates in non-insulin-dependent diabetes mellitus. Gjessing HJ; Damsgaard EM; Matzen LE; Frøland A; Faber OK Diabetes Care; 1987; 10(5):558-62. PubMed ID: 3315512 [TBL] [Abstract][Full Text] [Related]
14. Progressive deterioration of beta-cell function in nonobese type 2 diabetic subjects. Postprandial plasma C-peptide level is an indication of insulin dependency. Prando R; Odetti P; Melga P; Giusti R; Ciuchi E; Cheli V Diabetes Metab; 1996 Jun; 22(3):185-91. PubMed ID: 8697306 [TBL] [Abstract][Full Text] [Related]
15. Residual B cell function in patients with long-standing NIDDM and its relation to metabolic control and diabetic complications. Iwase M; Kikuchi M; Nunoi K; Maki Y; Wakisaka M; Wada M; Fujishima M Endocrinol Jpn; 1988 Dec; 35(6):803-8. PubMed ID: 3074917 [TBL] [Abstract][Full Text] [Related]
16. Pancreatic B-cell function in non-insulin-dependent diabetes mellitus during successive periods of sulfonylurea and insulin treatment: serum C-peptide response to glucagon and urine C-peptide excretion. Hsieh SD; Iwamoto Y; Matsuda A; Kuzuya T Endocrinol Jpn; 1987 Aug; 34(4):561-7. PubMed ID: 3315640 [TBL] [Abstract][Full Text] [Related]
17. The C-peptide response to glucagon injections in IDDM and NIDDM patients. Poulsen S; Billesbølle P; Kølendorf K; Thorsteinsson B Horm Metab Res; 1985 Jan; 17(1):39-40. PubMed ID: 3967844 [No Abstract] [Full Text] [Related]
18. C-peptide response to glucagon in young diabetics. Juang JH; Huang BY; Huang HS; Lin JD; Huang MJ Taiwan Yi Xue Hui Za Zhi; 1989 Jun; 88(6):579-83. PubMed ID: 2677232 [TBL] [Abstract][Full Text] [Related]
19. [Plasma C-peptide assay and the clinical significance]. Kaku K; Nagasaka Y; Kaneko T Nihon Rinsho; 1990 Feb; 48 Suppl():48-50. PubMed ID: 2192142 [No Abstract] [Full Text] [Related]
20. Abnormal glucose modulation of islet A- and B-cell responses to arginine in non-insulin-dependent diabetes mellitus. Dimitriadis GD; Pehling GB; Gerich JE Diabetes; 1985 Jun; 34(6):541-7. PubMed ID: 3891467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]